BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26415707)

  • 41. The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.
    Nagel F; Santer D; Stojkovic S; Kaun C; Schaefer AK; Krššák M; Abraham D; Bencsik P; Ferdinandy P; Kenyeres E; Szabados T; Wojta J; Trescher K; Kiss A; Podesser BK
    Exp Gerontol; 2019 May; 119():193-202. PubMed ID: 30763602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The compendium of matrix metalloproteinase expression in the left ventricle of mice following myocardial infarction.
    Kaminski AR; Moore ET; Daseke MJ; Valerio FM; Flynn ER; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H706-H714. PubMed ID: 32083973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
    Antonov IB; Kozlov KL; Pal'tseva EM; Polyakova OV; Lin'kova NS
    Bull Exp Biol Med; 2018 Mar; 164(4):550-553. PubMed ID: 29504111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice.
    Tao ZY; Cavasin MA; Yang F; Liu YH; Yang XP
    Life Sci; 2004 Feb; 74(12):1561-72. PubMed ID: 14729404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.
    de Castro Brás LE; Cates CA; DeLeon-Pennell KY; Ma Y; Iyer RP; Halade GV; Yabluchanskiy A; Fields GB; Weintraub ST; Lindsey ML
    Antioxid Redox Signal; 2014 Nov; 21(14):1974-85. PubMed ID: 24382150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
    Voloshenyuk TG; Gardner JD
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ski drives an acute increase in MMP-9 gene expression and release in primary cardiac myofibroblasts.
    Landry N; Kavosh MS; Filomeno KL; Rattan SG; Czubryt MP; Dixon IMC
    Physiol Rep; 2018 Nov; 6(22):e13897. PubMed ID: 30488595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.
    Lindsey ML; Escobar GP; Mukherjee R; Goshorn DK; Sheats NJ; Bruce JA; Mains IM; Hendrick JK; Hewett KW; Gourdie RG; Matrisian LM; Spinale FG
    Circulation; 2006 Jun; 113(25):2919-28. PubMed ID: 16769909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness.
    Carrick-Ranson G; Spinale FG; Bhella PS; Sarma S; Shibata S; Fujimoto N; Hastings JL; Levine BD
    Exp Gerontol; 2019 Aug; 123():36-44. PubMed ID: 31095969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcription factor PEX1 modulates extracellular matrix turnover through regulation of MMP-9 expression.
    Jurado Acosta A; Rysä J; Szabo Z; Moilanen AM; Komati H; Nemer M; Ruskoaho H
    Cell Tissue Res; 2017 Feb; 367(2):369-385. PubMed ID: 27826738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomic identification of matrix metalloproteinase substrates in the human vasculature.
    Stegemann C; Didangelos A; Barallobre-Barreiro J; Langley SR; Mandal K; Jahangiri M; Mayr M
    Circ Cardiovasc Genet; 2013 Feb; 6(1):106-17. PubMed ID: 23255316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases].
    Zhao Y; Zhou X; Liao X; Yang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):790-5. PubMed ID: 19734590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-associated changes in cardiac matrix and integrins.
    Burgess ML; McCrea JC; Hedrick HL
    Mech Ageing Dev; 2001 Oct; 122(15):1739-56. PubMed ID: 11557277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac remodeling in erythropoietin-transgenic mice.
    Briest W; Homagk L; Baba HA; Deten A; Rassler B; Tannapfel A; Wagner KF; Wenger RH; Zimmer HG
    Cell Physiol Biochem; 2004; 14(4-6):277-84. PubMed ID: 15319531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice.
    Ogawa T; Nikawa T; Furochi H; Kosyoji M; Hirasaka K; Suzue N; Sairyo K; Nakano S; Yamaoka T; Itakura M; Kishi K; Yasui N
    Am J Physiol Cell Physiol; 2005 Sep; 289(3):C697-707. PubMed ID: 16100390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased matrix metalloproteinase activity in the kidneys of hereditary nephrotic mice (ICGN strain).
    Uchio K; Manabe N; Tamura K; Miyamoto M; Yamaguchi M; Ogura A; Yamamoto Y; Miyamoto H
    Nephron; 2000 Oct; 86(2):145-51. PubMed ID: 11014984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
    Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.